This document provides instructions for administering an intradermal injection. It begins by explaining that intradermal injections are used to diagnose tuberculosis, identify allergens, and administer local anesthetics. The document then outlines the proper technique for an intradermal injection, including using a short needle at a 10-15 degree angle in the epidermis layer and observing for the formation of a small bleb. It emphasizes preparing the correct dosage, cleaning the injection site, and proper disposal of needles after injection. The goal is to inject the medication accurately into the intradermal tissue for absorption.

1. Administering an
Intradermal Injection
Presented By
Mrs.Usha Rani Kandula, MSc(N),
Assistant professor in Adult health nursing, Department of Clinical
nursing, Arsi University, College of health sciences, Asella, Ethiopia,
Institutional email: usharani2020@arsiun.edu.et.

2. Intradermal Injection
-Intradermal (ID) or intra cutaneous injections are typically used to
diagnose tuberculosis, identify allergens, and administer local
anesthetics.
-The site below the epidermis is the location for administering ID
injections;
drugs are absorbed slowly from this site.
-The sites commonly used for ID injection are the inner aspect of the
forearm (if it is not highly pigmented or covered with hair), upper chest,
and upper back beneath the scapula .

3. -Only small amounts of water-soluble medication should be used for
subcutaneous injections.
-The drug’s dosage for an ID injection is usually contained in a small
quantity of solution (0.01 to 0.1 ml).
-A 1-ml tuberculin syringe with a short bevel, 25 to 27 gauge, 3/8- to
1/2-inch needle is used to provide accurate measurement.
-If repeated doses are ordered, the site should be rotated.
-ID injections are administered into the epidermis layer by angling the
needle 10° to 15° to the skin.

6. Equipment
 Medication administration record (MAR)
 Sterile tuberculin syringe and short bevel, 25 to 27 gauge, 3/8- to
1/2-inch needle or insulin syringe.
 Medication to be administered.
 Alcohol swab and sterile 2 × 2 gauze pad
 Disposable gloves

7. Sl.No Action Rationale
1 Check with the client and the chart for
any
known allergies.
Prevents the occurrence of
hypersensitivity reactions such as hives,
urticaria, or anaphylactic shock.
2 Wash hands. Reduces transmission of microorganisms.
3 Follow the rights of drug
administration.
Promotes client safety.
4 -Prepare the medication from an
ampoule or vial;
-refer to Procedure 29-2 or 29-3 as
appropriate.
-Take the medication to the client’s
room and place on a clean surface.

8. Sl.No Action Rationale
5 Check the client’s identification arm
band.
Accurately identifies the client.
6 Explain the procedure to the client. Reduces the client’s anxiety and
enhances
cooperation.
7 Place the client in a comfortable
position; provide for privacy.
Promotes comfort. Promotes absorption of
the medication. Decreases anxiety.
8 Wash hands and don non sterile
gloves.
Decreases contact with blood and body
fluids.
9 Select and clean the site. Promotes absorption of the drug; reduces
trauma to the body’s tissue.

9. Sl.No Action Rationale
Assess the client’s skin for bruises,
redness,
or broken tissue.
Select an appropriate site using
appropriate anatomic landmarks.
Cleanse the site with an alcohol wipe
using a firm circular motion;
-cleanse from inside to outside; allow
alcohol to dry.
Aids in the removal of microorganisms
on
the skin.
10 Prepare the syringe for injection. Ensures correct dosage of medication
in the
syringe.
Remove the needle guard.
• Express any air bubbles from the
syringe.

10. Sl.No Action Rationale
11 Inject the medication.
Hold the syringe in dominant hand.
With non dominant hand, grasp the
client’s
dorsal forearm and gently pull the skin
taut
on ventral forearm(Figure 29-20).
Taut skin facilitates needle insertion.
-Place the needle close to the skin,
bevel side up.
-Insert the needle at a 10° to 15° angle
until resistance is felt, and advance the
needle approximately 3 mm below the
skin surface; the needle’s tip should be
visible under the skin.
Ensures that medication is injected into
the
intradermal tissue; initial resistance
indicates
the needle’s tip is in the subcutaneous
region.

11. Sl.No Action Rationale
-Administer the medication slowly;
observe
the development of a bleb (large flaccid
vesicle that resembles a mosquito bite).
-If none appears, withdraw the needle
slightly.
Indicates that the medication was injected
into the dermis.
Withdraw the needle.
Pat area gently with a dry 2 × 2 sterile
gauze pad.
Prevents spreading the medication
beyond
the point of injection.
Do not massage the area after
removing the needle.
12 Discard the needle and syringe in a
sharps
container.
Prevents needle sticks.

12. Sl.No Action Rationale
13 Remove gloves, dispose of in
appropriate receptacle, and wash
hands.
Reduces the spread of microorganisms.
14 Observe for signs of an allergic
reaction.
Ensures client safety.
15 Draw a circle around the peri meter of
the bleb with a ball point pen.
Allows for easy recognition and
observation of the injection site.
16 Document medication and site of
injection on the MAR.
Provides a written description of the
injection site and states the time the
medication was administered.
Thanking you